KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Gains from Investment Securities (2016 - 2025)

TherapeuticsMD filings provide 15 years of Gains from Investment Securities readings, the most recent being $105000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities changed 0.0% to $105000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $105000.0, a 0.0% change, with the full-year FY2025 number at $105000.0, changed 0.0% from a year prior.
  • Gains from Investment Securities hit $105000.0 in Q4 2025 for TherapeuticsMD, up from $51000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $23.5 million in Q2 2021 to a low of -$721000.0 in Q3 2023.
  • Median Gains from Investment Securities over the past 5 years was $52000.0 (2025), compared with a mean of $1.6 million.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 48400.0% in 2023 and later surged 75262.32% in 2025.
  • TherapeuticsMD's Gains from Investment Securities stood at -$39000.0 in 2021, then surged by 541.03% to $172000.0 in 2022, then surged by 1243.6% to $2.3 million in 2023, then plummeted by 95.46% to $105000.0 in 2024, then changed by 0.0% to $105000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $105000.0 (Q4 2025), $51000.0 (Q3 2025), and $51000.0 (Q2 2025) per Business Quant data.